Related Experiment Videos
Visualizing Emerging Trends and Global Hotspots in Ozempic, Weight Loss, and Pancreatitis Research: A Scientometric
Fran Espinoza-Carhuancho1, Berly Delgado-Cumpa2, Abigail Temoche2
1Department of Academic, Bibliometrics, Evidence Evaluation, and Systematic Reviews (BEERS) Group, School of Human Medicine, Universidad Científica del Sur, Lima, Peru.
Purpose:
To visualize emerging trends and areas of global interest in research related to Ozempic, weight loss, and pancreatitis using scientometric tools to analyze literature published between January 2008 and January 2025.
Methods:
A descriptive scientometric analysis was performed by searching the Web of Science Core Collection database. The software CiteSpace and/or Bibliometrix were used to generate knowledge maps, co-citation networks, and keyword co-occurrence networks. A total of 115 documents were identified through a search that included the keywords "Ozempic," "weight loss," and "pancreatitis." The documents were filtered and selected according to predefined inclusion and exclusion criteria.
Results:
A stable scientific production was evidenced by the publication of a total of 115 documents in 72 journals, highlighting "Cureus Journal of Medical Science" and "Diabetes Obesity & Metabolism" as the most productive. Several different relevant thematic clusters were identified, "adverse event," and "incretins." At the level of thematic evolution, one finds that semaglutide as a term has been coming into its own in the last several years and is seen as related to obesity and type 2 diabetes. The network reflects growing interrelationships between clinical medicine, nursing, and medicinal chemistry to stimulate additional collaborative inquiry.
Conclusions:
This research identified the major topic areas, authors, and most relevant collaborative networks that address the patient needs and challenges presented by Ozempic, weight loss, and pancreatitis.